Call Now

Hypertensive Cerebral Arteriosclerosis Stroke (HCAS)

Lacunar infarcts and "hypertensive" primary intracerebral hemorrhages, collectively often referred to as hypertensive small vessel strokes, constitute about one third of all strokes. However, despite their public health importance, their etiopathogenesis remains ill-understood. Like all strokes, they are a heterogeneous entity, but the autopsy pathology evidence suggests that the majority are caused by a limited number of cerebral small vessel lesions. Small vessel atherosclerosis is causally implicated in a proportion of lacunar infarcts, although modern concepts of atherosclerotic plaque biology and natural history have yet to be applied to small cerebral vessels.

Organism species: Pan-species (General)

PRODUCT TYPE CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins N/A Recombinant Hypertensive Cerebral Arteriosclerosis Stroke (HCAS) Antigenic Transformation Customized Service Offer
Antibodies N/A Monoclonal Antibody to Hypertensive Cerebral Arteriosclerosis Stroke (HCAS) Monoclonal Antibody Customized Service Offer
N/A Polyclonal Antibody to Hypertensive Cerebral Arteriosclerosis Stroke (HCAS) Polyclonal Antibody Customized Service Offer
Assay Kits N/A CLIA Kit for Hypertensive Cerebral Arteriosclerosis Stroke (HCAS) CLIA Kit Customized Service Offer
N/A ELISA Kit for Hypertensive Cerebral Arteriosclerosis Stroke (HCAS) ELISA Kit Customized Service Offer